Genmab — April 2017

[nohope]

Hvis jeg har forstået det ret, så er det pinksheet afdelingen OTCMKTS er handler dem. De handledes torsdag, men ikke idag mandag. Det er ikke vigtigt, undrer mig bare.

[Solsen]

Godkendelsen i Canada kan have lukket handlen fra deres side. De aner ikke hvilken kurs vi åbner i

[Budweis]

Bør EU godkendelsen ikke komme i denne uge?

[bibob]

Ca. 67 dg. fra 23 februar. Omkring D. 1 maj.

[E_L]

Could be this week, press release Genmab February 24 said "A final decision by the European Commission is anticipated within two months."

[E_L]

And NICE /UKsecond commitee meeting April 20, but i dont know if they will make any announcements, as it says Expected
publication date July 2017

[bibob]

http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion/human/004077/WC500222148.pdf Nederst på siden står der 67 dg.

[digafarm]

Det må så være senest d. 27/4

[E_L]

EMA must be the correct one indeed. Guess Rachel didn't read the small print A few extra days of nervousness...

[JKY_VH]

I'm not worried about the approval. Dont worry be happy:-)

[digafarm]

Probably the friday news we have been longing for in two weeks time

[bibob]

God morgen

[bibob]

Ser ud til at GMXAY alligevel blev handlet i går. + 0,67. %.

[JKY_VH]

God morgen

[transalp]

Go morgen

[E_L]

FDA Grants Genentech’s Tecentriq (Atezolizumab) Accelerated Approval as Initial Treatment for Certain People with Advanced Bladder Cancer

[Helge_LarsenPI-redaktør]

God morgen.

[Sibelius]

@GlobalMacro, Thanks for sharing your thoughts. Totally agree with your line of thought re how investors and analysts need to see gradual proof of the pudding before upping targets and expectations.

[Sibelius]

I also agree that it is unlikely that Genmab remain independent for ten years more - or five for that matter.

[Sibelius]

However, before getting lost in P/E calculations etc., we should also consider what the strategy of the company is, and how this will change the operations and earings multiples.